Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AIV
12976
CALL
Aimco
AIV
$274M
| $25.5K | ﹤0.01% |
2,800
-6,900
| -71% | -$59.6K |
2020 Q4
16 quarters
|
|
|
PINC
12977
PUT
DELISTED
Premier
PINC
| $25.4K | ﹤0.01% |
1,200
-1,100
| -48% | -$23.3K |
2022 Q4
8 quarters
|
|
12978
PUT
Direxion Daily MSCI Mexico Bull 3X ETF
MEXX
$14.8M
| $25.4K | ﹤0.01% |
+2,800
| New | +$33.2K |
2024 Q4
0 quarters
|
|
12979
GraniteShares HIPS US High Income ETF
HIPS
$104M
| $25.4K | ﹤0.01% |
+1,978
| New | +$25.7K |
2024 Q4
0 quarters
|
|
12980
PUT
Disc Medicine
IRON
$2.37B
| $25.4K | ﹤0.01% |
400
-2,600
| -87% | -$150K |
2023 Q4
4 quarters
|
|
12981
PUT
InfuSystem Holdings
INFU
$265M
| $25.4K | ﹤0.01% |
3,000
+2,400
| +400% | +$18.9K |
2022 Q4
8 quarters
|
|
|
BPT
12982
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $25.3K | ﹤0.01% |
+46,545
| New | +$46.9K |
2024 Q4
0 quarters
|
|
12983
CALL
Immix Biopharma
IMMX
$805M
| $25.3K | ﹤0.01% |
11,500
+2,600
| +29% | +$4.75K |
2024 Q3
1 quarter
|
|
12984
CervoMed
CRVO
$49.7M
| $25.3K | ﹤0.01% |
10,811
-1,682
| -13% | -$16.4K |
2024 Q3
1 quarter
|
|
12985
Upland Software
UPLD
$10.9M
| $25.3K | ﹤0.01% |
583
-3,212
| -85% | -$104K |
2017 Q3
29 quarters
|
|
12986
PUT
Liberty Media Corporation Series A Common Stock
FWONA
$22.1B
| $25.2K | ﹤0.01% |
300
-400
| -57% | -$31.1K |
2022 Q4
8 quarters
|
|
|
SBDS
12987
PUT
DELISTED
Solo Brands Inc
SBDS
| $25.2K | ﹤0.01% |
553
-92
| -14% | -$4.56K |
2022 Q2
10 quarters
|
|
12988
Gain Therapeutics
GANX
$72.9M
| $25.1K | ﹤0.01% |
+11,612
| New | +$23.3K |
2024 Q4
0 quarters
|
|
12989
PUT
KNOT Offshore Partners
KNOP
$355M
| $25.1K | ﹤0.01% |
4,600
-13,200
| -74% | -$79.7K |
2022 Q3
9 quarters
|
|
12990
CALL
VanEck Video Gaming and eSports ETF
ESPO
$249M
| $25K | ﹤0.01% |
300
-800
| -73% | -$63.9K |
2024 Q3
1 quarter
|
|
12991
Amplify Seymour Cannabis ETF
CNBS
$70.4M
| $25K | ﹤0.01% |
1,017
+360
| +55% | +$15.7K |
2024 Q3
1 quarter
|
|
12992
PUT
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.4B
| $25K | ﹤0.01% |
200
+100
| +100% | +$12.9K |
2024 Q2
2 quarters
|
|
12993
MultiSensor AI
MSAI
$10.4M
| $25K | ﹤0.01% |
+339
| New | +$24.8K |
2024 Q4
0 quarters
|
|
12994
PUT
MaxCyte
MXCT
$109M
| $25K | ﹤0.01% |
6,000
+4,000
| +200% | +$15.1K |
2022 Q4
8 quarters
|
|
12995
PUT
Ituran Location and Control
ITRN
$1.04B
| $24.9K | ﹤0.01% |
800
-22,800
| -97% | -$648K |
2022 Q2
10 quarters
|
|
12996
CALL
Lexicon Pharmaceuticals
LXRX
$779M
| $24.9K | ﹤0.01% |
33,700
+14,700
| +77% | +$17.7K |
2018 Q1
27 quarters
|
|
|
ZYXI
12997
CALL
DELISTED
Zynex
ZYXI
| $24.8K | ﹤0.01% |
3,100
+2,900
| +1,450% | +$23.9K |
2024 Q3
1 quarter
|
|
12998
CALL
Enliven Therapeutics
ELVN
$3.08B
| $24.8K | ﹤0.01% |
1,100
+1,000
| +1,000% | +$25.9K |
2024 Q2
2 quarters
|
|
|
BELFB
12999
PUT
Bel Fuse Inc Class B
BELFB
$3.74B
| $24.7K | ﹤0.01% |
300
-4,100
| -93% | -$332K |
2022 Q4
8 quarters
|
|
13000
Skillful Craftsman
EDTK
$16.5M
| $24.5K | ﹤0.01% |
23,824
-2,116
| -8% | -$2.14K |
2022 Q1
11 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.